Loading...
Symbols:
Loading...
Symbols:
Generex Biotechnology Corp. (GNBT)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Generex Biotechnology Corp. (GNBT)
17 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on GNBT
- RJ Steffens (6)
- Word on the Street(4)
- ChinaBio Today(3)
- H.S. Ayoub(1)
- Trade Radar Operator(1)
Most popular authors
(tracked in watchlists)
- Trade Radar Operator(87)
- ChinaBio Today(61)
- Mike Huckman(52)
- Word on the Street(25)
- RJ Steffens (6)
Most commented on authors
- RJ Steffens (40)
- Biotech Boldman (8)
- Mike Huckman(7)
- ChinaBio Today(4)
- Word on the Street(0)
- Four Drug Companies Vying for Diabetes Patients
- Generex Biotechnology and the USMCI: Armed with Antigens in the War Against Breast Cancer
- ADA's 68th Scientific Sessions: A New Look at Insulin Therapy
- Generex Biotech's Oral-lyn Granted Special Access Authorization by Health Canada
- Fixing Pfizer
- Biotech in Review: Positive Consolidation in China Life Science Companies
- Generex Biotech: A Breath of Fresh Insulin
- Oral Insulin: Balancing Safety with Efficacy
- Generex Biotechnology: Oral-lyn Buccal Insulin Takes Center Stage
- Can Generex Biotech Add to Recent Gains?
- China Biotech Week in Review: Anesiva Forms JV with Fosun Pharma
- Generex To Test Cancer Vaccine in China
- Generex Biotech Soars On Strong Rodman & Renshaw Coverage
- Generex Biotech Breast Cancer Vaccine Success a Threat to Genentech?
- Generex Vaccine Shows Anti-Tumor Activity
- Generex Biotech Stock Perks Up on Patent News
- Generex Biotech on the Move
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »